ovarian serous carcinoma

ovarian carcinoma that has material basis in the lining of the ovary and produces a serum-like fluid

Wikimedia Commons category is Ovarian serous carcinoma

ovarian serous carcinoma is …
instance of (P31):
class of diseaseQ112193867

sublass of (P279):
serous carcinomaQ7455058
ovarian carcinomaQ18556145
ovarian serous tumorQ19000698

External links are
P699Disease Ontology IDDOID:0050933
P2888exact matchhttp://identifiers.org/doid/DOID:0050933
http://purl.obolibrary.org/obo/DOID_0050933
P11956Experimental Factor Ontology ID0002917

P5008on focus list of Wikimedia projectWikiProject MedicineQ4099686

Reverse relations

main subject (P921)
Q92336127A Comprehensive Review of Ovarian Serous Carcinoma
Q91470904A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
Q35980522A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006
Q82293644A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases
Q88072881APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival
Q85655227AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma
Q40115732Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.
Q85327489Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
Q40523803B7-H4 expression in ovarian serous carcinoma: a study of 306 cases
Q92845245Bleeding and bowel obstruction in giant ovarian serous carcinoma - a video vignette
Q44261967Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
Q26998068Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma
Q98499784Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma
Q79918669Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma
Q64115689Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers
Q35575176Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.
Q92248873Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma
Q84782227Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology
Q55452489Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
Q33751321Comparative secretome of ovarian serous carcinoma: Gelsolin in the spotlight
Q67947147Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma
Q72632226Concurrent ovarian serous carcinoma and osteogenesis imperfecta
Q92131983Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
Q46314878Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion
Q53286591Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion.
Q92524991Differential expression of immune related genes in high-grade ovarian serous carcinoma
Q33233449Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma
Q38971615ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy
Q34978084Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
Q39208636Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients
Q74099950Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma
Q80262379Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma
Q41219933Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival
Q44544392Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium
Q81475966Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival
Q44053802Expression of cyclooxygenase-2 in ovarian serous carcinoma: correlation with angiogenesis, nm23 expression and survival.
Q37388641Expression of p-Akt in ovarian serous carcinoma and its association with proliferation and apoptosis
Q37229341Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival
Q39203802FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome
Q37050667Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages
Q44618222Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
Q79934949Grading ovarian serous carcinoma using a two-tier system
Q83811112HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
Q83188780HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma
Q45953122HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Q51753726High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
Q47150076High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism
Q89421055Immunostaining Study on the Expression of NF-κB, ER, and PR in Ovarian Serous Carcinoma
Q92332337Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database
Q53082153Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.
Q57791800Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis
Q80456258Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma
Q91812790Low Grade Ovarian Serous Carcinoma - A Clinical-Morphologic Study
Q74310041Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases
Q91648665Mediastinal metastasis from ovarian serous carcinoma 29 years after initial treatment
Q92321835Metastatic Carcinoma of Endometrium from Primary Ovarian Serous Carcinoma Mimicking a Primary Uterine Tumour
Q62112710Metastatic Ovarian Serous Carcinoma Presenting as Inflammatory Breast Cancer: A Case Report
Q48164105Metastatic Ovarian Serous Carcinoma of the Breast.
Q36553567Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases
Q36037099Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
Q73144573Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
Q33327971NM23 as a prognostic biomarker in ovarian serous carcinoma
Q103738182Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report
Q46008296Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern.
Q92867921Ovarian serous carcinoma in synthetic mesh: A rare case report and review of the literature
Q57764870Ovarian serous carcinoma presenting with mediastinal lymphadenopathy 20 months before the intraabdominal mass: Role of immunohistochemistry
Q26822545Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
Q85055443Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression
Q40389999PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors
Q30434644PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma
Q58088279Peritoneal Carcinomatosis From Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma
Q80550802Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma
Q38306666Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions
Q86746941Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma
Q30461903Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma
Q46988991Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis
Q64083343Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
Q89868575Surprise Lymph Node Histology in a Patient with Ovarian Serous Carcinoma
Q71544451Syndrome of inappropriate antidiuresis in ovarian serous carcinoma with neuroendocrine differentiation
Q36624703The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma
Q41747755The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Q79080812The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinoma
Q100497506The immune complex p53 protein/anti-p53 autoantibodies in the pathogenesis of ovarian serous carcinoma
Q81872426The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma
Q95499783Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site
Q81377645Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma
Q50663650VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival.
Q81223439Virchow's node as a first manifestation of ovarian serous carcinoma: case report
Q83415067[Clinical significance of two-tier grading system of ovarian serous carcinoma]
Q82986986[Evaluation of two-tier grading system and significance of p53 protein over-expression in ovarian serous carcinoma]
Q83249807[Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma]
Q73153525beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma
Q39145559miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.

Q18556985ovary serous adenocarcinomasubclass ofP279
Q28444998CD274 Expressionpositive prognostic predictor forP3358

The articles in Wikimedia projects and languages

      Category:Ovarian serous carcinomawikimedia

Search more.